首页|期刊导航|Traditional Medicine Research|Integration of network pharmacology and metabolomics to elucidate Qi-Xiong-Qu-Yu decoction mitigates myocardial ischemia via regulating Nrf2/ROS/MAPK signaling

Integration of network pharmacology and metabolomics to elucidate Qi-Xiong-Qu-Yu decoction mitigates myocardial ischemia via regulating Nrf2/ROS/MAPK signalingOA

中文摘要

Background:Qi-Xiong-Qu-Yu decoction(QXD)is an empirical herbal formula developed for the clinical treatment of ischemic heart disease.Methods:Isoproterenol(ISO)was used to establish a rat model of myocardial ischemia,and the effects of QXD were evaluated.The chemical profile of QXD was identified using UPLC-Q-Exactive-MS.Network pharmacology was then performed based on the UPLC-MS identified constituents and GEO datasets,and plasma metabolomics was employed to predict the molecular signaling.Finally,cell and animal experiments were conducted to verify the predicted results.Results:QXD exerted therapeutic effects in ISO-induced myocardial ischemia rats.A total of 23 constituents were identified in QXD via UPLC-MS.Integrated network pharmacology and metabolomics analyses indicated that regulation of the Nrf2/ROS/MAPK pathway may underlie the anti-myocardial ischemia effects of QXD.In vivo,QXD significantly lowered the elevated serum levels of myocardial injury biomarkers(cTnT,CK-MB,and LDH)and decreased myocardial MDA levels,attenuated cardiomyocyte apoptosis and myocardial fibrosis,and restored the activities of antioxidant enzymes including SOD and GSH-Px.In vitro,QXD reduced the release of cTnT,CK-MB,and LDH into the cell culture supernatant,decreased intracellular ROS and MDA levels,and increased SOD activity in ISO-stimulated H9C2 cells.Our study suggests that the cardioprotective effects of QXD may be mediated by promoting the nuclear accumulation of Nrf2,which upregulates the expression of antioxidant enzymes,thereby inhibiting the activation of MAPK signaling.Conclusion:QXD mitigated ISO-induced myocardial ischemia in rats,and the underlying molecular mechanisms are closely associated with the suppression of cardiomyocyte apoptosis via the Nrf2/ROS/MAPK pathway.

Li-Ping Chen;Hang-Hang Gou;Cheng-Xun He;Ya-Mei Wu;Wei Peng;Yun-Hui Chen;Jun Chen

School of Pharmacy,School of Basic Medical Sciences,CDUTCM-KEELE Joint Health and Medical Sciences Institute,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,ChinaSchool of Pharmacy,School of Basic Medical Sciences,CDUTCM-KEELE Joint Health and Medical Sciences Institute,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,ChinaSchool of Pharmacy,School of Basic Medical Sciences,CDUTCM-KEELE Joint Health and Medical Sciences Institute,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,China Hospital of Chengdu University of Traditional Chinese Medicine,Chengdu University of Traditional Chinese Medicine,Chengdu 610032,ChinaSichuan Academy of Chinese Medicine Sciences,Chengdu 610041,ChinaSchool of Pharmacy,School of Basic Medical Sciences,CDUTCM-KEELE Joint Health and Medical Sciences Institute,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,ChinaSchool of Pharmacy,School of Basic Medical Sciences,CDUTCM-KEELE Joint Health and Medical Sciences Institute,Chengdu University of Traditional Chinese Medicine,Chengdu 611137,ChinaHospital of Chengdu University of Traditional Chinese Medicine,Chengdu University of Traditional Chinese Medicine,Chengdu 610032,China

医药卫生

Qi-Xiong-Qu-Yu decoctionmyocardial ischemianetwork pharmacologymetabolomicsNrf2/ROS/MAPK signalingcell apoptosis

《Traditional Medicine Research》 2027 (1)

P.13-26,14

supported by Sichuan Science and Technology Program(No.2025ZNSFSC0582)International Cooperation and Exchange Project of Science&Technology Department of Sichuan Province(No.23GJHZ0100,2017HH0004)Sichuan Provincial Administration of Traditional Chinese Medicine(No.2021MS464).

10.53388/TMR2027002

评论